Guardant Health
GH
#2992
Rank
HK$33.87 B
Marketcap
HK$274.20
Share price
-0.82%
Change (1 day)
30.35%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -HK$4 Billion

According to Guardant Health 's latest financial reports the company's current earnings are HK$0.69 Billion. In 2023 the company made an earning of -HK$3.73 Billion, an increase over its 2022 earnings that were of -HK$5.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$4 Billion7.33%
2023 -HK$3.73 Billion-26.73%
2022 -HK$5.09 Billion69.96%
2021 -HK$3 Billion56.35%
2020 -HK$1.92 Billion252.69%
2019 -HK$0.55 Billion-17.22%
2018 -HK$0.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.66 Billion-58.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.25 Billion-93.84%๐Ÿ‡บ๐Ÿ‡ธ USA